We measured steady-state levels of the human globin mRNAs in liver samples from several mid-gestational fetuses. RNA from the (, y, 8, r, 0, and a globin genes were present in fetal liver samples isolated from 10-25-wk embryos. The abundance of all human globin mRNAs declined in older fetuses, presumably because of a gradual reduction in the proportion of erythroid precursors in the liver as development procedes. The 'y:, globin mRNA ratio in 10-18-wk fetal erythroblasts was 6-7:1, and in adult erythroid bone marrow the ratio was 0.02:1. In fetal liver samples, the relative abundance of E transcripts was < 1% that of y, and r transcripts < 5% that of a. Embryonic transcripts declined in abundance during late fetal development and were not detected in newborn liver or adult erythroid bone marrow. 0 globin mRNA also represented a minor species (< 1% that of a) in fetal liver samples, but in contrast to the embryonic mRNAs, was most abundant in adult marrow samples obtained from patients with erythroid hyperplasia. These results support the hypothesis that globin protein levels are regulated by the relative amounts of each globin mRNA at various stages of erythropoietic development.
Introduction
The human ,8-like globin genes (5'-E-G-A are located on the short arm of chromosome 11 and are expressed consecutively during development. The human a-like genes (5'-I-frl-4,6a2-i&al-a2-al-01-3') are located on the long arm of chromosome 16 , and are also developmentally regulated (1, 2) . The embryonic globin genes, E and A, are transcriptionally active in yolk sac-derived erythroblasts (3) . When hematopoiesis shifts to the liver at 5-9 wk of development, these megaloblastic yolk sac-derived red cells stop being produced, since the yolk sac becomes atretic and involutes at this time (4) . Erythroid precursors derived from early fetal livers contain hypomethylated and transcriptionally active y-globin genes (5-7), and fetal hemoglobin (a2Y2) is the predominant hemoglobin formed during the entire period of fetal erythropoiesis (1, 2, 8) . However, the "adult" fl-globin gene must also be actively expressed in fetal erythroblasts, since a number of investigators have shown that hemoglobin A (a2,82) comprises 5-15% of the newly synthesized hemoglobin in fetuses as young as 10 weeks (8) (9) (10) (11) (12) (13) ). Changes in rates of globin biosyn-thesis at various stages of development are probably due to changes in the rates oftranscription of each ofthe globin genes at "appropriate" developmental times. However, this hypothesis has not yet been directly tested, since intact fetal livers from several stages ofdevelopment have not been widely available for RNA analysis.
We performed this study to define steady-state levels of globin mRNAs present in fetal livers at mid-to late gestation. Our results show that relative amounts of embryonic, fetal, and adult hemoglobins are probably determined by the relative concentrations of corresponding globin mRNAs at various stages of development, implying that these events may be controlled by the rates of transcription of each of these genes.
The embryonic globin genes (E and O) are minimally expressed in early fetal livers, gradually declining to undetectable levels in adult bone marrow. In contrast, the newly discovered 0 globin gene (14) (15) (16) (17) (18) produces very low levels of mRNA in fetal and adult erythroid cells.
Methods
Human liver samples. Normal adult human liver was obtained at the time of organ donation (19 
Results
We first measured the relative abundance of E, y, and # globin mRNAs in fetal and adult erythroid tissues. The organization of the probes used for these analyses are shown at the bottom of Fig. 1 . E, y, and # globin exon 2 sequences are 77-87% conserved, and each contains a Bam HI site 209 nucleotides (nt)' from the 5' end of this exon on the noncoding strand.
Correctly processed c, -y, or # globin exon 2 mRNAs would be expected to protect probe fragments of 209 nt from S1 digestion; the positions ofthese fragments are indicated on the right side ofthe figure. Despite considerable homology of e, y, and , exon 2, each probe is absolutely specific for its mRNA using these hybridization conditions. 20 ,ug of total cellular RNA from all samples was hybrid- (30, 31) , but was abundant in adult erythroid marrow RNA derived from the same patient described above.
The same RNAs were next analyzed with probes derived from the human r and a globin genes (Fig. 2) . The organization of these probes is shown at the bottom ofthis figure. Note that the nucleotide sequences of exons 1, 2, and 3 of the ¢, a, and 6 globin gene exhibit < 80% identity in the regions from which the probes were derived; each probe is therefore specific for its mRNA using the hybridization conditions listed in Methods. 20Mgg of RNA from each sample was hybridized with the rglobin probe, and the autoradiograph was exposed for 1 d (Fig. 2, The results ofthe 6 globin mRNA analysis are presented in Fig. 3 . Correctly processed 6 globin exon 3 is expected to protect a probe fragment of 151 nt from SI digestion. Longer probe fragments consistent with splicing intermediates were also detected using with this probe (data not shown); the levels of these intermediates paralleled levels of correctly spliced ( mRNA. The autoradiographs depicted in Fig. 3 were exposed for 5 d. Since 20 jig of RNA was analyzed, the relative sensitivity of the 6 mRNA assay was 40 times that of the a mRNA analysis. Small amounts of6 globin mRNA are present in early fetal liver samples and gradually decline during development, consistent with the patterns seen for all the other globin genes. K562 cells contain 0 globin mRNA, and the level increases slightly with two days of hemin treatment. 6 globin mRNA is most abundant in adult erythroid bone marrow derived from the patient with homozygous sickle cell anemia, but was not detected in normal bone marrow RNA, consistent with a previous report (17) . In a separate experiment, the sickle cell marrow sample was found to contain at least 10 times more y globin mRNA than the normal marrow sample (data not shown). Since both individuals had < 2% circulating fetal hemoglobin, we presume that this difference is due to the enrichment of erythroid precursors in the sickle cell marrow sample. Analysis of bone marrow RNA derived from four individuals with homozygous ( thalassemia revealed essentially the same relative abundance of 6 globin mRNA (Fig. 3 B) . No r globin transcripts were detected in any of the bone marrow samples, even though r mRNA is more abundant than 6 in K562 cells (compare lanes 1, 2 vs. 3-8 in Fig. 3 B) .
In order to accurately represent the relative abundance of each globin mRNA at various stages of development, we simultaneously end-labeled all six globin probes to approximately the same specific activity, and analyzed RNA derived from 10-and 18-wk fetal livers or adult erythroid bone marrow. 2. . It is therefore difficult to make comparisons of absolute mRNA levels except for the A-like genes, which possess identical labeled ends and duplex lengths. Nonetheless, these data clearly demonstrate that y, fl, and a globin are major mRNAs, and A, (, and 0 globin are minor mRNAs in fetal and adult erythroid cells.
The same RNAs used for the preceding SI analyses were also examined with control nonglobin probes; 5 gug of total cellular RNA was slotted in triplicate onto nitrocellulose filters and subsequently hybridized to three different uniformly labeled probes (Fig. 5) . The relative abundance of f-actin mRNA in fetal liver samples gradually declines with development. In contrast, the relative abundance of ceruloplasmin mRNA reaches a peak in mid-gestation, declines, and then dramatically increases in abundance in the newborn and adult liver samples. Ceruloplasmin mRNA is not detected in K562 cells, but is present in adult erythroid marrow, reflecting the ceruloplasmin mRNA present in bone marrow macrophages (27) . c-myc exon 2 mRNA is present in trace amounts in early fetal liver samples. It is abundant in the rapidly dividing K562 cells, but is barely detected in hemin-induced K562 cells (23) or adult erythroid bone marrow samples.
Discussion
In this study, we isolated RNA from several fetal and adult liver samples that were stored at -90'C for up to 20 yr before RNA preparation. The ability to harvest RNA from these samples allowed us to examine globin RNA content at several points during gestation. We have shown that the relative abundance ofglobin mRNA is greatest in early fetal livers, and gradually declines to minimal levels in newborn liver. The relative abundance of each globin mRNA species parallels the relative abundance of newly synthesized globin proteins, as previously measured by several investigators (9-13). The embryonic globin genes were expressed at highest levels in early fetal liver samples, and their expression declined to undetectable levels in adult bone marrow. The newly discovered 0 glo- bin gene (14) (15) (16) (17) (18) is also expressed at low levels in fetal liver samples, but its mRNA is most abundant in bone marrow cells derived from adult patients with sickle cell anemia or fl-thalassemia.
The relative abundance ofall the globin mRNAs was greatest in fetal liver samples derived from embryos of 10 or 13 wk gestation but subsequently declined, consistent with the notion that the relative proportion of erythroid cells gradually diminishes during fetal liver development. The presence oferythroid precursors in human fetal livers of 5-20 wk gestation has been demonstrated by a number of workers based on routine morphologic analysis, including electron micrography (37-39). Several studies have demonstrated that erythropoietic precursors are at least as abundant as hepatic parenchymal cells in mid-gestational fetal livers; myeloid precursors comprise a much smaller fraction of the cells (40) (41) (42) . In the only quantitative morphometric analysis of cell populations during rat fetal liver development, Greengard et al. (43) found that hematopoietic cells accounted for about 60-70% of total liver cells at mid-gestation, decreasing to about 50% at term and to less than 5% in the early postnatal livers. All of these studies are consistent with our findings of gradually declining globin mRNA abundance in older fetal livers, owing to reduced numbers of erythroid precursors in these samples.
The y:, globin mRNA ratio is approximately 6-7:1 between 10 and 18 wk of gestation, and the ratio appears to gradually decline until it is approximately equivalent in newborn liver. Neither y nor ,3 mRNA was detected in adult liver cells, and the y:, mRNA ratio was 0.02:1.0 in adult erythroid tissue derived from a patient in whom -2% of the circulating hemoglobin was fetal. These data corroborate a number of studies that described rates of globin biosynthesis in the livers and reticulocytes of fetuses at various stages of development. (45) . However, we could not detect E or v globin transcripts in bone marrow RNAs derived from several patients with erythroid hyperplasia. Again, these results are corroborated by recent studies that did not detect embryonic globin proteins in normal adult blood samples using monoclonal antibodies directed against the embryonic globin chains (45, 46) .
Very small amounts ofcorrectly spliced 0 globin transcripts are present in all fetal liver samples and in adult erythroid bone marrow cells. The 0 globin gene therefore appears to be co-regulated with the a globin genes, but is always expressed at lower levels. The 6 globin gene, which encodes the ,8-like chain that contributes to the formation of hemoglobin A2 (a262), is COregulated with the 3 globin gene, but is always expressed at much lower levels, since this gene is dysfunctional or "thalassemic" (47) . Since the 0 globin gene is co-regulated with the linked a globin genes, but expressed at much lower levels, the relationship between 9 and a globin gene expression is reminiscent of the relationship between 6 and ft globin gene expression.
0-Globin mRNA is present in the human erythroleukemia cell line K562. Despite the "embryonic-fetal" phenotype of K562 cells, 6 globin transcripts ("adult"-like) are also present in these cells (30) . The finding of 0 globin transcripts in K562 cells is therefore consistent with their fetal-adult pattern of expression in vivo. Recently, Leung et al. (17) and Hsu et al. (18) reported the presence of correctly initiated and correctly terminated 0 globin transcripts in K562 cells. In addition, Leung and colleagues also detected trace amounts of 0 globin mRNA in yolk sac-derived cells and in a fetal liver sample of unspecified age. No 0 globin mRNA could be detected in normal adult bone marrow RNA samples examined in their study or in ours. However, bone marrow samples derived from patients with sickle cell anemia or homozygous jB-thalassemia did contain small amounts of 0 globin mRNA. Since these marrows are usually more than 80% erythroid, erythroid-specific mRNAs may be enriched manifold in these samples when compared with normal marrow. For this reason, we suspect that the ability to detect 0 globin transcripts in these marrows is due to the enrichment of erythroid cells that contain 0 globin mRNA, not abnormal regulation of this gene. However, the possibility exists that this gene may be activated in the erythroid precursors of patients with accelerated erythropoeisis. Because 0 globin mRNA is a minor transcript at all stages of development, we are not surprised that deletion of this gene does not lead to an identifiable phenotype (48, 49) . The relative abundance of this mRNA is always less than 1% that of a globin, and thus it could only participate in the formation of a minor hemoglobin. The presence ofthis globin in fetal or adult red cells remains speculative, since no candidate molecules have yet been identified. Further studies will be required to determine whether this apparently functional mRNA is in fact translated into 0 globin chains.
In conclusion, this study provides further evidence that rates of hemoglobin biosynthesis in vivo are probably determined by the relative abundance of each globin mRNA; that is, hemoglobin "switching" is probably mediated at the level of transcription. Presumably, soluble protein factors (50) and a regulatory "clock" (51) are both partially responsible for transcriptional switching, but the precise nature of this event remains unknown. Studies comparing transcriptional factors in fetal and adult erythroid cells will hopefully yield clues regarding the molecular basis of this process.
